YAL004W Antibody

What is YAL004W and what is its significance in Saccharomyces cerevisiae research?

YAL004W is a gene designation in Saccharomyces cerevisiae (strain ATCC 204508 / S288c), corresponding to UniProt accession number P39703 . This systematic nomenclature follows the standard yeast gene naming convention, where "Y" indicates a yeast gene, "A" refers to chromosome I, "L" denotes the left arm of the chromosome, and "004W" indicates it is the fourth open reading frame on that chromosome arm, read in the Watson (5' to 3') direction.

The protein encoded by YAL004W plays roles in cellular processes that can be effectively studied using antibody-based detection methods. Understanding its function contributes to our knowledge of fundamental eukaryotic cellular processes that are often conserved from yeast to humans, making S. cerevisiae an excellent model organism for this research.

What application methods are recommended for YAL004W antibody?

YAL004W antibody (CSB-PA336613XA01SVG) can be applied in multiple experimental techniques commonly used in yeast research . Based on standard protocols for yeast antibodies, the following applications are typically recommended:

• Western blotting: For detecting YAL004W protein in cell lysates, typically using 1:1000 to 1:5000 dilutions depending on antibody sensitivity and protein abundance.

• Immunoprecipitation: For isolating YAL004W protein and its binding partners from cell lysates.

• Immunofluorescence microscopy: For determining subcellular localization, similar to techniques used for other yeast proteins such as Blm10 .

• ChIP assays: If YAL004W has DNA-binding properties or associates with chromatin.

Before designing experiments, researchers should validate the antibody's performance in their specific application and strain background.

What controls should be included when using YAL004W antibody?

Proper control inclusion is critical for interpreting results with YAL004W antibody:

• Positive control: Wild-type yeast strain known to express YAL004W protein.

• Negative control: Ideally, a YAL004W deletion strain (YAL004W-Δ) to confirm antibody specificity.

• Loading control: For Western blots, include detection of a housekeeping protein (e.g., actin) to normalize protein loading across samples.

• Isotype control: For immunofluorescence, include a non-specific antibody of the same isotype to assess background staining.

• Secondary antibody only control: To detect non-specific binding of the secondary antibody.

Proper controls are essential for distinguishing true signal from background, particularly given the challenges of antibody validation highlighted by initiatives like YCharOS that have found variability in antibody performance across the proteome .

What is the optimal protocol for using YAL004W antibody in Western blotting?

For optimal Western blotting results with YAL004W antibody:

• Sample preparation:

  • Harvest yeast cells in mid-log phase

  • Lyse cells using glass bead disruption in buffer containing protease inhibitors

  • Clear lysate by centrifugation (14,000 × g, 10 minutes)

  • Determine protein concentration via Bradford assay

• Gel electrophoresis and transfer:

  • Load 20-50 μg total protein per lane

  • Separate proteins on 10-12% SDS-PAGE

  • Transfer to PVDF membrane at 100V for 1 hour or 30V overnight

• Antibody incubation:

  • Block membrane with 5% non-fat milk in TBST for 1 hour

  • Incubate with YAL004W antibody (1:1000-1:2000 dilution) overnight at 4°C

  • Wash 3× with TBST, 5 minutes each

  • Incubate with appropriate HRP-conjugated secondary antibody for 1 hour

  • Wash 3× with TBST, 5 minutes each

• Detection:

  • Apply ECL substrate and detect signal using film or digital imager

  • Expected molecular weight should be verified against protein databases

This protocol follows similar principles to those used for other yeast proteins and should be optimized based on protein abundance and antibody characteristics.

How can I optimize YAL004W antibody use for immunofluorescence microscopy?

For successful immunofluorescence with YAL004W antibody in yeast:

• Cell preparation:

  • Grow cells to early exponential phase (10⁶-10⁷ cells/mL)

  • Fix by adding 3.7% formaldehyde directly to the medium for at least 1 hour

  • Convert to spheroplasts using Zymolyase 100T (50 μg/mL) in 0.1M potassium phosphate buffer (pH 7.5) with 2 μL/mL 2-mercaptoethanol

  • Gently pellet cells between steps to prevent damage

• Antibody staining:

  • Apply YAL004W primary antibody (1:100-1:500 dilution)

  • Incubate overnight at 4°C or 2 hours at room temperature

  • Wash 3× with PBS

  • Apply fluorophore-conjugated secondary antibody

  • Include DAPI (1 μg/mL) for nuclear counterstaining

• Imaging considerations:

  • Use appropriate filter sets for fluorophore detection

  • Capture z-stack images for proper localization assessment

  • Apply deconvolution for improved resolution

This protocol is based on successful immunofluorescence techniques used for other yeast proteins as described in the literature , and may require optimization for YAL004W-specific characteristics.

What approaches can verify the specificity of YAL004W antibody?

Verifying antibody specificity is crucial for research integrity:

• Genetic validation:

  • Compare signal between wild-type and YAL004W deletion strains

  • Complementation with tagged YAL004W to confirm co-localization

  • Observe signal reduction upon RNAi-mediated knockdown (if applicable)

• Biochemical validation:

  • Peptide competition assay: pre-incubate antibody with excess immunizing peptide

  • Mass spectrometry identification of immunoprecipitated proteins

  • Western blot detection of protein at correct molecular weight

• Advanced validation:

  • Comparison of results from multiple antibodies targeting different epitopes

  • Cross-validation with orthogonal techniques (e.g., GFP-tagging)

  • Validation across multiple batches and experimental conditions

These approaches align with recommendations from YCharOS and other antibody validation initiatives that emphasize knockout validation as a gold standard for antibody characterization .

How can YAL004W antibody be used for co-immunoprecipitation studies?

For co-immunoprecipitation (co-IP) studies with YAL004W antibody:

• Lysate preparation:

  • Use gentle lysis buffers to preserve protein-protein interactions

  • Include appropriate protease inhibitors and phosphatase inhibitors if studying phosphorylation-dependent interactions

  • Pre-clear lysate with Protein A/G beads to reduce non-specific binding

• Immunoprecipitation procedure:

  • Conjugate YAL004W antibody to Protein A/G beads or use pre-coupled magnetic beads

  • Incubate with cleared lysate (4 hours to overnight at 4°C with gentle rotation)

  • Wash beads 4-5 times with buffer containing reduced detergent

  • Elute bound proteins with SDS sample buffer or specific peptide elution

• Interaction analysis:

  • Analyze co-precipitated proteins by Western blot for known/suspected partners

  • For unbiased discovery, use mass spectrometry to identify all bound proteins

  • Validate interactions with reciprocal co-IPs and controls for specificity

• Controls and validation:

  • Include IgG control to identify non-specific binding

  • Confirm interactions are not mediated by DNA/RNA (add nucleases if necessary)

  • Validate key interactions with alternative methods (e.g., proximity ligation assay)

This approach can be adapted from established protocols for co-IP studies in yeast, such as those used for studying Blm10 interactions with the proteasome .

What troubleshooting approaches help resolve weak or non-specific YAL004W antibody signals?

When facing issues with YAL004W antibody performance:

• Weak signal troubleshooting:

  • Increase antibody concentration or incubation time

  • Enhance antigen retrieval or extraction methods

  • Optimize blocking conditions to reduce non-specific binding

  • Use more sensitive detection systems (e.g., enhanced chemiluminescence substrates)

  • Enrich for target protein through fractionation or immunoprecipitation

• Non-specific binding troubleshooting:

  • Increase washing stringency (more washes, higher salt concentration)

  • Optimize blocking conditions (try different blocking agents)

  • Reduce antibody concentration

  • Pre-adsorb antibody with yeast lysate from deletion strain

  • Use monovalent antibody fragments to reduce binding to Fc receptors

• Signal validation approaches:

  • Compare multiple antibody lots or sources

  • Confirm results with orthogonal methods (e.g., mass spectrometry)

  • Use epitope-tagged YAL004W expressed at endogenous levels

These approaches reflect standard troubleshooting strategies for yeast antibodies and should be adapted based on specific experimental conditions.

How can YAL004W antibody be combined with fluorescent protein tagging for in vivo studies?

For combining antibody-based detection with fluorescent protein tagging:

• Complementary tagging strategies:

  • N-terminal YFP fusion, similar to approaches used for Blm10

  • Verify tag doesn't interfere with protein function through complementation assays

  • Use antibody to validate expression and localization seen with fluorescent tag

• Live-cell imaging with fixed-cell immunofluorescence correlation:

  • Capture live-cell dynamics with fluorescent protein tag

  • Fix same cells and perform immunofluorescence with YAL004W antibody

  • Correlate localization patterns to validate both approaches

• Advanced applications:

  • Use antibody to detect post-translational modifications not visible with fluorescent tags

  • Combine with super-resolution microscopy for detailed localization

  • Perform fluorescence recovery after photobleaching (FRAP) to study protein dynamics

• Analysis methods:

  • Apply automated image analysis tools like Fluorcal for quantitative assessment of localization patterns

  • Use colocalization analysis to measure spatial relationships with other cellular structures

  • Implement time-lapse imaging to correlate temporal dynamics with antibody-detected states

These approaches build on successful fluorescent protein fusion techniques demonstrated for other yeast proteins like Blm10 .

What methodologies can quantify YAL004W protein expression levels accurately?

For precise quantification of YAL004W protein:

• Western blot quantification:

  • Use standard curves with recombinant protein or peptide standards

  • Employ fluorescent secondary antibodies for wider linear detection range

  • Apply digital image analysis software with background correction

  • Normalize to multiple housekeeping proteins for accurate relative quantification

• ELISA development:

  • Develop sandwich ELISA using YAL004W antibody as capture or detection antibody

  • Create standard curves with purified recombinant protein

  • Validate assay specificity using knockout controls

  • Optimize sample preparation to maximize antigen accessibility

• Mass spectrometry-based quantification:

  • Use antibody for immunoprecipitation combined with targeted MS

  • Apply selected reaction monitoring (SRM) for sensitive detection

  • Include isotope-labeled peptide standards for absolute quantification

  • Validate results by comparing antibody-based enrichment with direct MS

• Single-cell analysis:

  • Adapt immunofluorescence protocols for quantitative image cytometry

  • Calibrate fluorescence intensity using standard beads

  • Combine with flow cytometry for high-throughput quantification

  • Correlate with mRNA levels using simultaneous RNA-FISH

These quantitative approaches should be validated across multiple experimental conditions and biological replicates to ensure reproducibility.

How should researchers design experiments to study YAL004W function under stress conditions?

For investigating YAL004W function under stress:

• Experimental design considerations:

  • Include time-course analysis to capture dynamic responses

  • Test multiple stress conditions (oxidative, DNA damage, heat shock, nutrient depletion)

  • Use both acute and chronic stress exposures to distinguish immediate vs. adaptive responses

  • Apply appropriate genetic backgrounds (wild-type, deletion, point mutants)

• Phleomycin stress response study design:

  • Based on protocols used for Blm10 studies, test YAL004W response to phleomycin-induced DNA damage

  • Use concentration range (0.1-0.35 μg/mL) with appropriate controls

  • Measure protein expression, localization, and post-translational modifications

  • Correlate with phenotypic outcomes (survival, growth rate, DNA integrity)

• Controls and validation:

  • Include known stress-responsive proteins as positive controls

  • Use deletion strains to confirm antibody specificity under stress conditions

  • Validate key findings with orthogonal methods (e.g., epitope tagging)

• Data integration:

  • Correlate protein-level changes with transcriptomic data

  • Analyze protein-protein interactions specific to stress conditions

  • Map post-translational modifications induced by stress

This approach adapts established stress response protocols to specifically investigate YAL004W function, similar to studies performed for Blm10 and its role in DNA damage response .

What considerations apply when interpreting contradictory results from different detection methods?

When faced with conflicting data:

This approach reflects best practices in antibody-based research and aligns with principles advocated by antibody validation initiatives like YCharOS .

How can researchers effectively combine YAL004W antibody-based data with genomic and proteomic datasets?

For integrated multi-omics approaches:

• Data integration strategies:

  • Correlate YAL004W antibody-detected protein levels with transcriptomic data

  • Map post-translational modifications using antibody-based enrichment followed by mass spectrometry

  • Integrate protein localization data with interactome databases

  • Analyze temporal dynamics across multiple data types

• Computational approaches:

  • Apply machine learning techniques like ensemble-of-trees methods to identify patterns across datasets

  • Use Bayesian models to integrate antibody-based quantification with other data types

  • Develop network models incorporating protein-protein interaction data

  • Implement visualization tools for multi-dimensional data exploration

• Validation methods:

  • Confirm key predictions with targeted experiments

  • Use orthogonal techniques to validate integrated models

  • Apply genetic perturbations to test predicted relationships

  • Collaborate with computational biologists for specialized analysis

• Resource utilization:

  • Leverage public databases like Saccharomyces Genome Database

  • Compare findings with published large-scale studies

  • Contribute standardized data to community resources

  • Apply FAIR principles (Findable, Accessible, Interoperable, Reusable) to data management

This approach leverages advanced computational methods like those described in ensemble-of-trees research to maximize insights from antibody-generated data in the context of other biological information.